Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/39851| metadata.artigo.dc.title: | Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies |
| metadata.artigo.dc.creator: | Gao, Jianjun Tian, Zhenxue Yang, Xu |
| metadata.artigo.dc.subject: | COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) 2019-nCoV Pneumonia Chloroquine |
| metadata.artigo.dc.date.issued: | 2020 |
| metadata.artigo.dc.identifier.citation: | GAO, J.; TIAN, Z.; YANG, X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends, [S.l.], v. 14, n. 1, 2020. |
| metadata.artigo.dc.description.abstract: | The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future. |
| metadata.artigo.dc.identifier.uri: | https://www.jstage.jst.go.jp/article/bst/14/1/14_2020.01047/_article http://repositorio.ufla.br/jspui/handle/1/39851 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.